The relationship between sodium intake and mortality: a case-cohort study in a population-based cohort of 148,000 adults with both 24-hour and spot urine samples
钠摄入量与死亡率之间的关系:一项病例队列研究,研究对象为 148,000 名成年人,其中包括 24 小时尿液样本和点尿样本
基本信息
- 批准号:10565524
- 负责人:
- 金额:$ 54.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-23 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectBlood PressureCardiovascular DiseasesCardiovascular systemCause of DeathCessation of lifeCohort AnalysisCohort StudiesConsumptionDataEventFood SupplyFormulationHealthHourIndividualIntakeMeasuresNetherlandsParticipantPopulationPotassiumPublic HealthReportingResearchResearch PersonnelRiskSample SizeSamplingShapesSodiumSodium ChlorideSpottingsTestingTimeUrineblood pressure reductioncohortcomparativedesigndietary guidelinesfollow-uphealthy aginghigh riskmortalitymortality riskpopulation basedrandomized trialstem
项目摘要
PROJECT SUMMARY
The largest cohort studies on the subject to date have found that adults with a low estimated sodium intake
had a higher risk of mortality than those with a sodium intake close to the population’s average. These findings
of a “J-shaped” sodium-mortality association have important implications for public health efforts on salt
because they suggest that reducing sodium intake at the population level could cause harm among a large
proportion of the population. Many investigators have criticized these cohort studies for their use of a spot
urine, rather than the gold-standard 24-hour urine sample, to estimate sodium intake. Thus far, however, the
debate on the shape of the sodium-mortality association could not be settled convincingly because analyses of
cohort studies that collected 24-hour urine samples have suffered from far smaller sample sizes than of those
that collected a spot urine. The overall objective of this project is to better understand the association of
sodium intake with mortality, particularly at levels of sodium intake below the population average in the US.
The central hypothesis is that the J-shape of the sodium-mortality association that has been reported by some
investigators is a result of bias from assessing sodium intake through use of a spot rather than a 24-hour urine
sample. This central hypothesis will be tested by pursuing three specific aims: 1) Determine the range of
sodium intake among adults that is associated with the lowest risk of all-cause mortality; 2) Determine whether
the commonly reported increased risk of mortality at low levels of sodium intake stems from using a spot urine
(rather than the gold-standard 24-hour urine) to estimate 24-hour sodium intake; and 3) Establish whether the
association of sodium intake with cardiovascular causes of death is the main determinant of the shape of the
sodium-mortality association. Using a case-cohort design, this project will analyze the sodium and potassium
concentration in urine samples collected as part of Lifelines, which is a population-based cohort study focused
on healthy aging in the Northern Netherlands. The Lifelines cohort has three unique features that enable the
investigators to make an important contribution to resolving the controversy about the J-shaped sodium-
mortality association: 1) Lifelines has collected two 24-hour urine samples from its participants; 2) with 147,888
adult participants and over 6,000 deaths (over a 15-year follow-up period), the Lifelines cohort has a far larger
sample size and number of deaths than any other cohorts that have collected 24-hour urine samples; and 3)
Lifelines has additionally collected a spot urine sample from all participants such that we are able to directly
compare the shape of the sodium-mortality association depending on whether a spot or the gold-standard 24-
hour urine sample is used. This project is significant because it will inform dietary guidelines on salt, and
whether public health efforts should attempt to lower sodium intake among the entire population (e.g., through
reformulation of the food supply) or focus instead only on individuals who consume high levels of sodium.
项目概要
迄今为止关于该主题的最大队列研究发现,估计钠摄入量较低的成年人
与钠摄入量接近人群平均水平的人相比,死亡风险更高。
“J 形”钠与死亡率关联对于盐的公共卫生工作具有重要意义
因为他们认为减少人口水平的钠摄入量可能会对大量人群造成伤害
许多研究人员批评这些队列研究使用了一个点。
然而,到目前为止,我们仍然使用尿液,而不是黄金标准的 24 小时尿液样本来估计钠摄入量。
关于钠与死亡率关联的形态的争论无法令人信服地得到解决,因为分析
收集 24 小时尿液样本的队列研究的样本量远小于其他研究的样本量。
该项目的总体目标是更好地了解尿液的关联性。
钠摄入量与死亡率的关系,特别是在钠摄入量低于美国人口平均水平的情况下。
中心假设是一些人报道的钠与死亡率的 J 形关联
研究人员通过使用点尿而不是 24 小时尿液来评估钠摄入量,从而产生了偏差
这个中心假设将通过追求三个具体目标来检验:1)确定范围。
成人的钠摄入量与全因死亡风险最低相关 2) 确定是否;
普遍报道的钠摄入量低时死亡风险增加的原因是使用点尿
(而不是金标准 24 小时尿液)来估计 24 小时钠摄入量;以及 3) 确定是否
钠摄入量与心血管死亡原因的关系是钠摄入量形状的主要决定因素
该项目将采用病例队列设计来分析钠和钾的含量。
作为生命线一部分收集的尿液样本中的浓度,这是一项基于人群的队列研究,重点关注
生命线队列具有三个独特的特征,使荷兰北部的健康老龄化成为可能。
研究人员为解决有关 J 形钠的争议做出了重要贡献
死亡率协会:1) Lifelines 收集了 147,888 名参与者的两份 24 小时尿液样本;
生命线队列有超过 6,000 名成年参与者死亡(超过 15 年的随访期)
样本量和死亡人数高于任何其他收集 24 小时尿液样本的队列;3)
生命线还从所有人那里收集了现场尿液样本,以便我们能够直接
根据点或金标准 24- 比较钠与死亡率关联的形状
使用小时尿液样本该项目意义重大,因为它将为有关盐的饮食指南提供信息,并且
公共卫生工作是否应尝试降低全体人口的钠摄入量(例如,通过
重新制定食品供应)或仅关注钠摄入量高的个体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pascal Geldsetzer其他文献
Pascal Geldsetzer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pascal Geldsetzer', 18)}}的其他基金
The impact of clinical interventions for sepsis in routine care and among detailed patient subgroups: A novel approach for causal effect estimation in electronic health record data
脓毒症临床干预措施对常规护理和详细患者亚组的影响:电子健康记录数据因果效应估计的新方法
- 批准号:
10505906 - 财政年份:2022
- 资助金额:
$ 54.57万 - 项目类别:
The impact of clinical interventions for sepsis in routine care and among detailed patient subgroups: A novel approach for causal effect estimation in electronic health record data
脓毒症临床干预措施对常规护理和详细患者亚组的影响:电子健康记录数据因果效应估计的新方法
- 批准号:
10686093 - 财政年份:2022
- 资助金额:
$ 54.57万 - 项目类别:
相似国自然基金
清达颗粒对Rab5a介导AMPK/PPARα通路调控脂质代谢稳态参与高血压心肌能量代谢重编程的影响研究
- 批准号:82374359
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
脑血管内皮细胞Piezo2对高血压脑出血的影响及其机制研究
- 批准号:82301500
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于单细胞测序和代谢组学分析四味土木香散对高血压性心肌肥厚的影响及分子机制
- 批准号:82360095
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
FTO蛋白影响Src mRNA m6A修饰重塑室旁核突触调控肥胖高血压的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:
醛固酮减弱血管内皮细胞时钟基因Bmal1震荡影响血压晨峰的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
Early Life Stress Induced Reprogramming of Vascular Function by the Endothelium and Macrophage Systems
生命早期的压力诱导内皮细胞和巨噬细胞系统对血管功能进行重新编程
- 批准号:
10555125 - 财政年份:2023
- 资助金额:
$ 54.57万 - 项目类别:
Identifying and testing a tailored strategy to achieve equity in blood pressure control in PACT
确定并测试量身定制的策略,以在 PACT 中实现血压控制的公平性
- 批准号:
10538513 - 财政年份:2023
- 资助金额:
$ 54.57万 - 项目类别:
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:
10643145 - 财政年份:2023
- 资助金额:
$ 54.57万 - 项目类别:
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
镰状细胞病的克隆造血和遗传变异
- 批准号:
10638404 - 财政年份:2023
- 资助金额:
$ 54.57万 - 项目类别:
The Injectrode- An injectable, easily removable electrode as a trial lead for baroreceptor activation therapy to treat hypertension and heart failure
Injectrode——一种可注射、易于拆卸的电极,作为压力感受器激活疗法的试验引线,以治疗高血压和心力衰竭
- 批准号:
10697600 - 财政年份:2023
- 资助金额:
$ 54.57万 - 项目类别: